(R)-tert-Butyl 1-cyclobutylpyrrolidin-3-ylcarbamate, 95.0%, 1g

2-Chloro-5-(trifluoromethyl)pyridine-3-boronic acid, 95.0%, 250mg

3,6,6-Trimethyl-4-oxo-4,5,6,7-tetrahydro-benzofuran-2-carboxylic acid, 95.0%, 1g

(S)-3-(hydroxymethyl)-N-((S)-1-(naphthalen-1-yl)ethyl)pent-4-enamide, 97%, 500mg

(S)-4-PHENYLPYRROLIDIN-2-ONE, 95.0%, 250mg

2-Bromo-6-nitrophenol>98.0%(GC)(T)5g

(S)-2-((tert-Butoxycarbonyl)amino)-3-(3,4,5-trifluorophenyl)propanoic acid, 95.0%, 250mg

Bosutinib, 99%, 10mg

(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-dimethyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine 6-oxide, 98%, 50mg

Indio en polvo, mínimo 99 %, pa, 5 g, envase de vidrio

2-(2-methylphenoxy)propanoic acid, 95.0%, 5g

(R,E)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid, 97.0%, 100g

Boc-D-Allylglycine, 98.0%, 1g